Welcome to our dedicated page for LINDSAY SEC filings (Ticker: LNN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on LINDSAY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into LINDSAY's regulatory disclosures and financial reporting.
Lindsay Corporation reported that its Board of Directors increased in size from seven to eight members and appointed Jahidul H. Khandaker as a director effective September 15, 2025. He will serve in the director class whose term expires at the January 2026 Annual Meeting and will join the Audit Committee.
Khandaker’s compensation will follow the existing program for non-employee directors described in the company’s November 20, 2024 proxy statement, and he has entered into the standard indemnification agreement previously filed in 2018. The company stated there are no related-party transactions or special arrangements tied to his appointment and furnished a press release about the appointment as an exhibit.
Lindsay Corporation entered into a Fourth Amendment to its Amended and Restated Revolving Credit Agreement with Wells Fargo Bank. The amendment continues to provide for a $50 million unsecured revolving credit facility and extends the facility’s termination date from August 26, 2026 to August 26, 2030. It also gives Lindsay the right, without premium or penalty, to terminate the facility or reduce its size.
The company and the bank also signed a First Modification to the Second Amended and Restated Line of Credit Note, extending its maturity date from August 26, 2026 to August 26, 2030. These changes help keep the company’s existing borrowing arrangements in place for a longer period under similar terms.
Lindsay Corporation filed a Form S-8 registration statement to register shares issuable under the Lindsay Corporation 2025 Long-Term Incentive Plan. This plan is intended for equity-based compensation awards to employees and other eligible participants.
The filing incorporates by reference Lindsay’s prior reports, including its Form 10-K for the year ended August 31, 2024, its Form 10-Q filings for the quarters ended November 30, 2024, February 28, 2025, and May 31, 2025, and certain Form 8-Ks. The company also outlines director and officer indemnification provisions under Delaware law, its certificate of incorporation, bylaws, indemnification agreements, and insurance coverage.
Lindsay Corporation director Robert E. Brunner reported sales of common stock on 08/13/2025, selling 1,332 and 1,856 shares in separate transactions at an average reported price of $142.08. Footnotes show the first sale ranged $142.05–$142.435 and the second $142.00–$142.185. After these transactions the filing reports Mr. Brunner beneficially owns 2,548 shares directly, 3,274 shares indirectly through Kiroki Investments, LLC, and 1,882 shares indirectly held by his spouse. The filing discloses restricted stock units that will vest on November 1, 2025, deferred settlements under the directors' nonqualified plan, and that Mr. Brunner is the sole manager of the LLC with sole voting and investment power.
The Form 144 filed for Lindsay Corporation reports a proposed resale of 3,188 shares of common stock, entered as two lots of 1,332 and 1,856 shares to be executed through Ameriprise on 08/13/2025. The filing lists combined aggregate market value of $452,131.54 and notes 10,862,203 shares outstanding, which is roughly 0.03% of outstanding shares. The shares were acquired as compensation on 11/01/2017, 11/01/2018 and 11/01/2021. The filer reports no sales in the past three months and affirms they do not possess undisclosed material adverse information.
Lindsay (NYSE:LNN) submitted its Form 10-Q for the quarter ended May 31 2025. The filing provides the normal set of quarterly financial statements, management’s discussion & analysis, market-risk disclosures, and controls & procedures.
No specific revenue, earnings, or cash-flow figures are disclosed in the excerpt provided, and the index shows no mention of extraordinary items, major legal matters, or transformational transactions. The company remains a large accelerated filer with 10.86 million shares outstanding as of June 24 2025.
Lindsay (NYSE:LNN) filed an 8-K on June 26, 2025 under Item 2.02 to furnish its fiscal Q3 2025 earnings press release and investor slide deck.
Exhibit 99.1 contains the full operating results for the quarter ended May 31, 2025, while Exhibit 99.2 provides the presentation that management will review on today’s 11:00 a.m. ET conference call. No financial figures are included in the body of the 8-K itself.
- Earliest event reported: 26-Jun-2025
- Information is “furnished,” not “filed,” limiting Section 18 liability
- No additional items on M&A, financing, litigation or governance
The filing simply notifies investors where to obtain detailed Q3 results and forward-looking commentary; it introduces no other material changes.